Bonita David P — SEC insider filings
SEC reporting owner CIK 1572451. 55 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers the 50 most recent of 55 filings on record, filed 2021-04-14 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 16 legs across 10 filings — 10,325,347 shares, $88,002,378 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 33 legs across 7 filings — 10,403,839 shares, $6,395,574 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 69.
- Largest priced transaction: purchase of 1,176,471 shares @ $17.00 ($20,000,007) in WINDWARD BIO GROUP AG, filed 2026-11-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| WINDWARD BIO GROUP AG (WWB) | Director, 10% owner | 3 | 1 leg · 1,176,471 sh · $20,000,007 | — | 8 |
| IMARA Inc. (IMRA) | Director, 10% owner | 4 | 2 legs · 3,333,332 sh · $19,999,992 | — | 2 |
| Prelude Therapeutics Inc (PRLD) | Director, 10% owner | 8 | 3 legs · 3,684,880 sh · $17,499,997 | — | 6 |
| Acutus Medical, Inc. (AFIB) | Director | 4 | 2 legs · 1,071,428 sh · $14,999,992 | — | 6 |
| ImageneBio, Inc. (IMA) | Director | 11 | 7 legs · 759,236 sh · $10,402,390 | — | 27 |
| Third Harmonic Bio, Inc. (THRD) | Director | 6 | 1 leg · 300,000 sh · $5,100,000 | — | 11 |
| Repare Therapeutics Inc. (RPTX) | Director | 10 | — | 30 legs · 122,892 sh · $4,189,939 | 4 |
| Tricida, Inc. (TCDA) | Director, 10% owner | 4 | — | 3 legs · 10,280,947 sh · $2,205,635 | 5 |
Insider filings — Bonita David P
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | WINDWARD BIO GROUP AG (WWB) | Purchase (P): 1,176,471 @ $17 · Conversion (C): 3,561,936 · Conversion (C): 1,611,008 · Option exercise (M): 216,668 @ $0.02 · Tax withholding (F): 232 @ $17 · Conversion (C): 3,561,936 (derivative) @ $0 · +2 more | EDGAR |
| 2026-11-16 | 4 | WINDWARD BIO GROUP AG (WWB) | Grant/award (A): 22,675 (derivative) @ $0 | EDGAR |
| 2026-11-12 | 3 | WINDWARD BIO GROUP AG (WWB) | Holdings only — no transactions reported | EDGAR |
| 2026-06-18 | 4 | ImageneBio, Inc. (IMA) | Grant/award (A): 15,600 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Prelude Therapeutics Inc (PRLD) | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | Prelude Therapeutics Inc (PRLD) | Purchase (P): 1,689,189 @ $4.44 · Purchase (P): 1,126,126 @ $4.44 | EDGAR |
| 2026-04-16 | 4 | ImageneBio, Inc. (IMA) | Purchase (P): 336,603 (derivative) · Purchase (P): 384,689 (derivative) | EDGAR |
| 2025-08-14 | 4 | Third Harmonic Bio, Inc. (THRD) | Other (J): 5,779,071 · Other (J): 43,584 (derivative) @ $0 | EDGAR |
| 2025-07-30 | 4 | ImageneBio, Inc. (IMA) | Option exercise (M): 379 · Purchase (P): 83,611 @ $29.90 · Option exercise (M): 17,520 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Prelude Therapeutics Inc (PRLD) | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Repare Therapeutics Inc. (RPTX) | Grant/award (A): 27,200 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Prelude Therapeutics Inc (PRLD) | Grant/award (A): 23,500 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Ikena Oncology, Inc. (IKNA) | Grant/award (A): 17,520 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Third Harmonic Bio, Inc. (THRD) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-09-21 | 4/A | Ikena Oncology, Inc. (IKNA) | Grant/award (A): 153,121 · Grant/award (A): 353,192 (derivative) | EDGAR |
| 2023-09-14 | 4 | Ikena Oncology, Inc. (IKNA) | Grant/award (A): 153,121 · Grant/award (A): 353,192 (derivative) | EDGAR |
| 2023-06-21 | 4 | Prelude Therapeutics Inc (PRLD) | Grant/award (A): 23,500 (derivative) @ $0 | EDGAR |
| 2023-06-15 | 4 | Acutus Medical, Inc. (AFIB) | Grant/award (A): 8,400 @ $0 · Grant/award (A): 19,600 (derivative) @ $0 | EDGAR |
| 2023-06-13 | 4 | Ikena Oncology, Inc. (IKNA) | Grant/award (A): 17,520 (derivative) @ $0 | EDGAR |
| 2023-06-12 | 4 | Repare Therapeutics Inc. (RPTX) | Grant/award (A): 27,200 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Third Harmonic Bio, Inc. (THRD) | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2023-05-24 | 4 | Prelude Therapeutics Inc (PRLD) | Purchase (P): 869,565 @ $5.75 | EDGAR |
| 2023-03-08 | 4 | Third Harmonic Bio, Inc. (THRD) | Disposition to issuer (D): 13,667 (derivative) · Grant/award (A): 13,667 (derivative) | EDGAR |
| 2022-11-25 | 4 | Tricida, Inc. (TCDA) | Sale (S): 1,034,421 @ $0.22 · Sale (S): 5,617,300 @ $0.21 · Sale (S): 3,629,226 @ $0.22 | EDGAR |
| 2022-10-27 | 4 | Third Harmonic Bio, Inc. (THRD) | Grant/award (A): 13,667 (derivative) @ $0 | EDGAR |
| 2022-09-21 | 4 | Third Harmonic Bio, Inc. (THRD) | Conversion (C): 5,479,071 · Purchase (P): 300,000 @ $17 · Conversion (C): 8,593,750 (derivative) · Conversion (C): 2,441,407 (derivative) · Conversion (C): 1,342,065 (derivative) | EDGAR |
| 2022-06-24 | 4 | Ikena Oncology, Inc. (IKNA) | Purchase (P): 66,806 @ $3.55 · Purchase (P): 23,419 @ $3.71 · Purchase (P): 65,965 @ $4.37 · Purchase (P): 96,035 @ $5.37 | EDGAR |
| 2022-06-22 | 4 | Prelude Therapeutics Inc (PRLD) | Grant/award (A): 34,300 (derivative) @ $0 | EDGAR |
| 2022-06-21 | 4 | Acutus Medical, Inc. (AFIB) | Grant/award (A): 8,400 @ $0 · Grant/award (A): 19,600 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | Tricida, Inc. (TCDA) | Grant/award (A): 27,207 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | Ikena Oncology, Inc. (IKNA) | Grant/award (A): 13,419 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | IMARA Inc. (IMRA) | Grant/award (A): 8,500 (derivative) @ $0 | EDGAR |
| 2022-05-16 | 4 | Repare Therapeutics Inc. (RPTX) | Grant/award (A): 49,000 (derivative) @ $0 | EDGAR |
| 2021-12-23 | 4 | Ikena Oncology, Inc. (IKNA) | Grant/award (A): 13,419 (derivative) @ $0 | EDGAR |
| 2021-11-17 | 4 | Tricida, Inc. (TCDA) | Grant/award (A): 666,667 @ $6 · Grant/award (A): 666,667 (derivative) | EDGAR |
| 2021-09-08 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 6,985 @ $34 · Sale (S): 212 @ $34 · Sale (S): 861 @ $33.93 · Sale (S): 26 @ $33.93 | EDGAR |
| 2021-09-02 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 8,223 @ $33.94 · Sale (S): 249 @ $33.94 · Sale (S): 12,586 @ $33.98 · Sale (S): 382 @ $33.98 · Sale (S): 15,941 @ $34.24 · Sale (S): 483 @ $34.24 | EDGAR |
| 2021-08-30 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 4,157 @ $34.52 · Sale (S): 126 @ $34.52 · Sale (S): 6,884 @ $33.94 · Sale (S): 209 @ $33.94 · Sale (S): 6,500 @ $33.92 · Sale (S): 197 @ $33.92 | EDGAR |
| 2021-08-25 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 16,886 @ $34.12 · Sale (S): 512 @ $34.12 · Sale (S): 2,852 @ $33.99 · Sale (S): 78 @ $33.99 | EDGAR |
| 2021-08-25 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 6,885 @ $34.06 · Sale (S): 209 @ $34.06 · Sale (S): 3,920 @ $34.07 · Sale (S): 119 @ $34.07 · Sale (S): 6,874 @ $34.34 · Sale (S): 208 @ $34.34 | EDGAR |
| 2021-08-19 | 4 | Repare Therapeutics Inc. (RPTX) | Sale (S): 16,886 @ $34.12 · Sale (S): 512 @ $34.12 · Sale (S): 2,852 @ $33.99 · Sale (S): 78 @ $33.99 | EDGAR |
| 2021-07-23 | 4/A | IMARA Inc. (IMRA) | Purchase (P): 1,666,666 @ $6 | EDGAR |
| 2021-07-21 | 4 | Acutus Medical, Inc. (AFIB) | Purchase (P): 714,285 @ $14 · Purchase (P): 357,143 @ $14 | EDGAR |
| 2021-07-16 | 4 | IMARA Inc. (IMRA) | Purchase (P): 1,666,666 @ $6 | EDGAR |
| 2021-06-30 | 4 | IMARA Inc. (IMRA) | Grant/award (A): 7,728 (derivative) @ $0 | EDGAR |
| 2021-06-22 | 4 | Acutus Medical, Inc. (AFIB) | Grant/award (A): 1,800 @ $0 · Grant/award (A): 7,022 (derivative) @ $0 | EDGAR |
| 2021-06-22 | 4 | Prelude Therapeutics Inc (PRLD) | Grant/award (A): 23,344 (derivative) @ $0 | EDGAR |
| 2021-06-11 | 4 | Tricida, Inc. (TCDA) | Grant/award (A): 16,403 @ $0 · Grant/award (A): 57,235 (derivative) @ $0 | EDGAR |
| 2021-05-14 | 4 | Repare Therapeutics Inc. (RPTX) | Grant/award (A): 21,000 (derivative) @ $0 | EDGAR |
| 2021-04-14 | 4/A | Ikena Oncology, Inc. (IKNA) | Conversion (C): 1,470,872 · Conversion (C): 42,614 · Purchase (P): 375,000 @ $16 · Purchase (P): 48,400 @ $16 · Conversion (C): 5,429,023 · Conversion (C): 157,288 · +10 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1572451 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs